Vinay Prasad claimed—but provided no evidence—that COVID-19 vaccines caused the death of 10 children.
The vaccine was fully protective in a small human challenge model, showing superior efficacy to the conventional 4-strain flu vaccine.
In a phase 3 trial, participants who received the shot were 29% less likely to be diagnosed with flu than those who received a conventional flu shot.
Early data from the UK and Japan show that the H3N2 subclade K was represented in 90% of flu samples.
High-dose vaccine was 40% more effective against hospitalization than the standard-dose version.
Our systematic review published this week shows that rigorous, transparent evidence synthesis can persist even when traditional advisory processes falter.
The large-scale project was conducted by the Center for Infectious Disease Research and Policy's Vaccine Integrity Project.
One study found fairly high rates of flu, mumps, and hepatitis A, and the other found that only 28% of adults have been vaccinated against tetanus and diphtheria.
Overall flu cases are 10.8% higher than last year across Australia.
Study shows vaccine effectiveness around 50% for both clinic visits and hospital stays for influenza during the 2025 Southern Hemisphere flu season.
